Free Trial
NYSE:CAH

Cardinal Health (CAH) Stock Price, News & Analysis

$111.40
+0.08 (+0.07%)
(As of 09/18/2024 ET)

About Cardinal Health Stock (NYSE:CAH)

Key Stats

Today's Range
$110.76
$112.06
50-Day Range
$93.74
$114.62
52-Week Range
$85.82
$116.05
Volume
1.26 million shs
Average Volume
2.10 million shs
Market Capitalization
$27.13 billion
P/E Ratio
49.51
Dividend Yield
1.81%
Price Target
$119.36
Consensus Rating
Moderate Buy

Company Overview

Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Cardinal Health Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks

Overall MarketRank™: 93rd Percentile

Cardinal Health scored higher than 93% of companies evaluated by MarketBeat, and ranked 59th out of 1,017 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Cardinal Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 7 buy ratings, 4 hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Cardinal Health has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Cardinal Health's stock forecast and price target.
  • Earnings Growth

    Earnings for Cardinal Health are expected to grow by 10.51% in the coming year, from $7.61 to $8.41 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Cardinal Health is 49.51, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 134.03.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Cardinal Health is 49.51, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 139.07.

  • Price to Earnings Growth Ratio

    Cardinal Health has a PEG Ratio of 1.55. PEG Ratios above 1 indicate that a company could be overvalued.

  • Read more about Cardinal Health's valuation and earnings.
  • Percentage of Shares Shorted

    3.96% of the float of Cardinal Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Cardinal Health has a short interest ratio ("days to cover") of 4.8.
  • Change versus previous month

    Short interest in Cardinal Health has recently increased by 42.92%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Cardinal Health pays a meaningful dividend of 1.80%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Cardinal Health has been increasing its dividend for 28 years.

  • Dividend Coverage

    The dividend payout ratio of Cardinal Health is 89.78%. Payout ratios above 75% are not desirable because they may not be sustainable.

  • Dividend Sustainability

    Based on earnings estimates, Cardinal Health will have a dividend payout ratio of 24.02% next year. This indicates that Cardinal Health will be able to sustain or increase its dividend.

  • Read more about Cardinal Health's dividend.
  • Percentage of Shares Shorted

    3.96% of the float of Cardinal Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Cardinal Health has a short interest ratio ("days to cover") of 4.8.
  • Change versus previous month

    Short interest in Cardinal Health has recently increased by 42.92%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Cardinal Health has a news sentiment score of 0.94. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.68 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 11 news articles for Cardinal Health this week, compared to 10 articles on an average week.
  • Search Interest

    Only 21 people have searched for CAH on MarketBeat in the last 30 days. This is a decrease of -49% compared to the previous 30 days.
  • MarketBeat Follows

    Only 11 people have added Cardinal Health to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Cardinal Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $12,379,980.00 in company stock.

  • Percentage Held by Insiders

    Only 0.15% of the stock of Cardinal Health is held by insiders.

  • Percentage Held by Institutions

    87.17% of the stock of Cardinal Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Cardinal Health's insider trading history.

CAH Stock News Headlines

Kamala Harris and The Woke Progressive Nightmare
New research from Jim Rickards - former advisor to the CIA - reveals shocking predictions about an “Election Meltdown” coming this November.
Argus Increases Cardinal Health (NYSE:CAH) Price Target to $125.00
Argus Research Reaffirms Their Buy Rating on Cardinal Health (CAH)
See More Headlines

CAH Stock Analysis - Frequently Asked Questions

Cardinal Health's stock was trading at $100.80 at the start of the year. Since then, CAH stock has increased by 10.5% and is now trading at $111.40.
View the best growth stocks for 2024 here
.

Cardinal Health, Inc. (NYSE:CAH) issued its quarterly earnings results on Wednesday, August, 14th. The company reported $1.84 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.74 by $0.10. Cardinal Health's revenue for the quarter was up 12.1% compared to the same quarter last year.
Read the conference call transcript
.

Cardinal Health subsidiaries include Mscripts, Mirixa Corporation, Patient Recovery Business of Medtronic, TelePharm, RainTree Oncology Services, NaviHealth, Outcomes Incorporated, and others.

Top institutional investors of Cardinal Health include Pacer Advisors Inc. (1.68%), AQR Capital Management LLC (1.42%), Acadian Asset Management LLC (1.07%) and LSV Asset Management (0.95%). Insiders that own company stock include Jason M Hollar, Jessica L Mayer, Stephen M Mason, Aaron E Alt, Deborah Weitzman, Ola M Snow, Michelle D Greene, Mary C Scherer and Michelle Brennan.
View institutional ownership trends
.

Shares of CAH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cardinal Health investors own include AbbVie (ABBV), AT&T (T), Johnson & Johnson (JNJ), CVS Health (CVS), Exxon Mobil (XOM), Pfizer (PFE) and Chevron (CVX).

Company Calendar

Ex-Dividend for 7/15 Dividend
7/01/2024
Dividend Payable
7/15/2024
Last Earnings
8/14/2024
Today
9/18/2024
Ex-Dividend for 10/15 Dividend
10/01/2024
Dividend Payable
10/15/2024
Next Earnings (Estimated)
11/01/2024
Fiscal Year End
6/30/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Drugs, proprietaries, & sundries
Sub-Industry
Health Care Distributors
CUSIP
14149Y10
Employees
48,900
Year Founded
1971

Price Target and Rating

Average Stock Price Target
$119.36
High Stock Price Target
$137.00
Low Stock Price Target
$101.00
Potential Upside/Downside
+7.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
12 Analysts

Profitability

Net Income
$852 million
Pretax Margin
0.53%

Debt

Sales & Book Value

Annual Sales
$226.83 billion
Cash Flow
$10.35 per share
Book Value
($13.19) per share

Miscellaneous

Free Float
243,202,000
Market Cap
$27.13 billion
Optionable
Optionable
Beta
0.60

Social Links

Should I Buy Cardinal Health Stock? CAH Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, September 10, 2024. Please send any questions or comments about these Cardinal Health pros and cons to contact@marketbeat.com.

Cardinal Health
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Cardinal Health, Inc.:

  • Cardinal Health's stock price has been showing positive momentum, currently trading at $112.72, with analysts forecasting further growth potential.
  • Strong analyst ratings with multiple firms giving "buy" and "strong buy" recommendations, indicating confidence in the company's performance.
  • Recent insider selling activities could be seen as a positive sign, as insiders usually have a good understanding of the company's prospects.
  • Cardinal Health operates as a healthcare services and products company, operating in multiple regions globally, providing diversification and growth opportunities.
  • Market consensus rating of "Moderate Buy" and an average price target of $118.45 suggest positive sentiment and potential upside for investors.

Cardinal Health
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Cardinal Health, Inc. for these reasons:

  • Despite positive analyst ratings, there is still a "sell" rating on the stock, indicating some concerns or uncertainties in the market.
  • The company's PE ratio of 50.10 may be considered high by some investors, potentially signaling overvaluation.
  • Recent insider selling activities, while viewed positively by some, could also raise questions about the company's future performance or internal outlook.
  • The stock's beta of 0.61 suggests lower volatility compared to the market, which may limit potential returns for more risk-seeking investors.
  • Cardinal Health's fifty-two week high of $116.04 may indicate a near-term resistance level that could impact short-term price movements.

This page (NYSE:CAH) was last updated on 9/19/2024 by MarketBeat.com Staff
From Our Partners